Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jozien Helleman

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Translational Andrology and Urology|March 30, 2018
Active surveillance for prostate cancer: a systematic review of contemporary worldwide practicesNetty Kinsella, Jozien Helleman, Sophie Bruinsma, et al.
The International Journal of Biochemistry & Cell Biology|January 20, 2010
MicroRNAs in ovarian cancer biology and therapy resistanceMarijn T M van Jaarsveld, Jozien Helleman, Els M J J Berns, et al.
International Journal of Cancer|December 10, 2002
Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicityJörgen Bierau, Albert H Van Gennip, René Leen, et al.
Translational Andrology and Urology|July 23, 2021
Using the Movember Foundation's GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function-a retrospective study in low-risk prostate cancer patientsR Trafford Crump, Sebastiaan Remmers, Mieke Van Hemelrijck, et al.
The International Journal of Biochemistry & Cell Biology|October 27, 2009
Integrated genomics of chemotherapy resistant ovarian cancer: a role for extracellular matrix, TGFbeta and regulating microRNAsJozien Helleman, Maurice P H M Jansen, Curt Burger, et al.
Gynecologic Oncology|February 6, 2010
Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big pictureJozien Helleman, Marcel Smid, Maurice P H M Jansen, et al.
Annals of Diagnostic Pathology|October 30, 2021
Improving the prediction of biochemical recurrence after radical prostatectomy with the addition of detailed pathology of the positive surgical margin and cribriform growthSebastiaan Remmers, Eva Hollemans, Daan Nieboer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 24, 2018
Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasisEva Hollemans, Esther I Verhoef, Chris H Bangma, et al.
Histopathology|January 17, 2020
Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomyEva Hollemans, Esther I Verhoef, Chris H Bangma, et al.
The American Journal of Surgical Pathology|October 9, 2019
Prostate Carcinoma Grade and Length But Not Cribriform Architecture at Positive Surgical Margins Are Predictive for Biochemical Recurrence After Radical ProstatectomyEva Hollemans, Esther I Verhoef, Chris H Bangma, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Translational Andrology and Urology|March 30, 2018
Active surveillance for prostate cancer: a systematic review of contemporary worldwide practicesNetty Kinsella, Jozien Helleman, Sophie Bruinsma, et al.
The International Journal of Biochemistry & Cell Biology|January 20, 2010
MicroRNAs in ovarian cancer biology and therapy resistanceMarijn T M van Jaarsveld, Jozien Helleman, Els M J J Berns, et al.
International Journal of Cancer|December 10, 2002
Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicityJörgen Bierau, Albert H Van Gennip, René Leen, et al.
Translational Andrology and Urology|July 23, 2021
Using the Movember Foundation's GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function-a retrospective study in low-risk prostate cancer patientsR Trafford Crump, Sebastiaan Remmers, Mieke Van Hemelrijck, et al.
The International Journal of Biochemistry & Cell Biology|October 27, 2009
Integrated genomics of chemotherapy resistant ovarian cancer: a role for extracellular matrix, TGFbeta and regulating microRNAsJozien Helleman, Maurice P H M Jansen, Curt Burger, et al.
Gynecologic Oncology|February 6, 2010
Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big pictureJozien Helleman, Marcel Smid, Maurice P H M Jansen, et al.
Annals of Diagnostic Pathology|October 30, 2021
Improving the prediction of biochemical recurrence after radical prostatectomy with the addition of detailed pathology of the positive surgical margin and cribriform growthSebastiaan Remmers, Eva Hollemans, Daan Nieboer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 24, 2018
Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasisEva Hollemans, Esther I Verhoef, Chris H Bangma, et al.
Histopathology|January 17, 2020
Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomyEva Hollemans, Esther I Verhoef, Chris H Bangma, et al.
The American Journal of Surgical Pathology|October 9, 2019
Prostate Carcinoma Grade and Length But Not Cribriform Architecture at Positive Surgical Margins Are Predictive for Biochemical Recurrence After Radical ProstatectomyEva Hollemans, Esther I Verhoef, Chris H Bangma, et al.
Pageof 5